Your email has been successfully added to our mailing list.

×
0 0 -0.000813008130081283 -0.000813008130081283 -0.00243902439024385 0.00162601626016257 0.00406504065040656 -0.00406504065040656
Stock impact report

Your Daily Scoop: Unum's Positive Data, Theravance's Treatment Benefit, Collectar's New Designation [Seeking Alpha]

UNUM THERAPEUTICS INC COMMON (UMRX) 
Last unum therapeutics inc common earnings: 3/26 07:30 am Check Earnings Report
Company Research Source: Seeking Alpha
Summary S tocks in the News Unum Therapeutics (NASDAQ: UMRX ), Theravance Biopharma (NASDAQ: TBPH ), Cellectar Biosciences (NASDAQ: CLRB ) Unum Therapeutics' ACTR707 shows encouraging action in blood cancer study Unum Therapeutics ( UMRX ) is a very early stage oncology targeted biopharma with a collaboration agreement with Seattle Genetics ( SGEN ), decent cash runway, and a platform. The company is developing a particular antibody platform called the Antibody-Coupled T-cell Receptor (ACTR) platform. The platform is “an autologous engineered T-cell therapy developed to combine with tumor-targeting antibodies to exert potent antitumor immune responses and tumor cell killing.” They further claim that the ACTR construct is “a modified ACTR construct that has been designed to allow the ACTR T cells to behave more favorably in immunosuppressive tumor microenvironments commonly found in solid tumor cancers.” The company announced on September 17 its plan Show less Read more
Impact Snapshot
Event Time:
UMRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for UMRX alerts
Opt-in for
UMRX alerts

from News Quantified
Opt-in for
UMRX alerts

from News Quantified